Movement Disorders edited by A.G. Donald, N.S. Shah.

The human nervous system-that most complex organization of energy and matter-has yielded a few glimmers of understanding of its operational me­ chanics during the last two decades. These have mostly been at the biochemical level of structure and function. Throughout history, as one of the mysteries...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Donald, A.G (Editor), Shah, N.S (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 1986.
Edition:1st ed. 1986.
Series:Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • Neuropharmacology of Movement Disorders: Comparison of Spontaneous and Drug-Induced Movement Disorders
  • I. Parkinson’s Disease
  • 1. Parkinsonism: Physiology and Pharmacology
  • 2. Role of B-Type Monoamine Oxidase Inhibition in the Treatment of Parkinson’s Disease: An Update
  • 3. Parkinson’s Disease: Current Concepts
  • 4. The Clinical Evaluation of Drug Therapy in Parkinsonism and Models of Dysfunction of Brain Dopamine Systems in Animals: A Review
  • II. Tardive Dyskinesia
  • 5. Tardive Dyskinesia: Epidemiology, Pathophysiology, and Pharmacology
  • 6. Tardive Dyskinesia and Subtyping of Schizophrenia
  • 7. Brain Peptides, Neuroleptic-Induced Tolerance, and Dopamine Receptor Supersensitivity: Implications in Tardive Dyskinesia
  • 8. Prevention of Tardive Dyskinesia
  • 9. Clinical Aspects of Tardive Dyskinesia; Epidemiology, Natural History, and Management
  • 10. Treatments for Tardive Dyskinesia: An Overview of Noncatecholaminergic/Noncholinergic Treatments
  • III. Tourette Syndrome and Tic
  • 11. Tourette Syndrome
  • 12. Clinical Management of Tourette Syndrome with Clonidine
  • 13. The Pathogenesis of Tourette Syndrome: A Review of Data and Hypotheses
  • IV. Huntington’s Disease
  • 14. Biochemical and Pharmacological Aspects of Movement Disorders in Huntington’s Disease
  • 15. The Effects of Neuroleptics on Longevity in Huntington’s Disease
  • V. Neuroleptic Drugs in the Production of Movement Disorders
  • 16. Movement Disorders Induced by Neuroleptic Drugs
  • 17. Movement Disorders and Neuroleptic Medication
  • 18. Drug-Induced Movement Disorders
  • 19. Movement Disorders Induced by Psychotherapeutic Agents: Clinical Features, Pathophysiology, and Management
  • 20. Pharmacotherapy of Movement Disorders in Children and Adolescents.